Johnson, M. L., Goldschmidt, J. H., Leal, T., Wang, S. Y., Brady, W. E., Hussein, M. A., Lietman, C., Windish, H., Calvet, C. Y., Dosunmu, L., Maniar, A., Tracy, L., Ready, N. E. (2026). TIGOS-LS, an open-label, randomized study of BMS-986489 (atigotatug + nivolumab fixed-dose combination) vs durvalumab as consolidation therapy following chemoradiotherapy in limited-stage small-cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps8134